CAPLIN POINT LAB LTD. Intrinsic Value
CAPLIPOINT · Healthcare · Current price ₹2,614.2
Is CAPLIN POINT LAB LTD. undervalued?
DocStoX estimates the fair value of CAPLIN POINT LAB LTD. at ₹1,260 per share, versus the current market price of ₹2,614. That puts the stock about -51.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹698), Relative P/E (₹2,558), Graham floor (₹947). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹698 (bear) to ₹1,260 (base) to ₹2,558 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹2,614 versus an intrinsic value of ₹1,260, CAPLIN POINT LAB LTD. currently offers -51.8% of negative margin (i.e. a premium).
More on CAPLIN POINT LAB LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.